Target intelligence / Profile preview

Lysosomal lumen

Molecular classification
Organelle, Cellular compartment
01

Overview

The lysosomal lumen is the acidic internal environment of the lysosome, a membrane-bound organelle essential for the degradation and recycling of macromolecules such as proteins, lipids, and polysaccharides. This compartment maintains a low pH (approximately 4.5–5.0) to optimize the activity of over 60 different acid hydrolases, which are critical for cellular waste management and homeostasis [1, 4]. Beyond degradation, the lysosomal lumen and its membrane serve as a signaling hub for nutrient sensing, particularly through the recruitment and activation of the mTORC1 complex [1]. Dysfunction in lysosomal processes is a hallmark of lysosomal storage diseases (LSDs), where the accumulation of undigested substrates leads to severe multi-systemic pathologies [2]. Furthermore, impaired lysosomal function is increasingly linked to neurodegenerative conditions like Parkinson's and Alzheimer's diseases, as well as cancer progression and drug resistance [2, 3]. Therapeutic strategies targeting the lysosomal lumen include lysosomotropic agents that alter pH, enzyme replacement therapies (ERT) to restore missing hydrolases, and small molecules designed to enhance lysosomal biogenesis or stability [3].

Other names
LysosomeLysosomal compartmentAcidic vacuoleLysosomal system
02

Mechanism of action

Modulation of lysosomal pH, inhibition of vacuolar-type H+-ATPase (V-ATPase), enzyme replacement therapy (ERT), or substrate reduction therapy (SRT).

03

Biological functions

Macromolecule degradationAutophagyNutrient sensingApoptosisAntigen presentationMetabolic signaling
04

Disease associations

Lysosomal storage diseaseNeurodegenerative diseaseCancerInfectionInflammation
05

Safety considerations

Lysosomal membrane permeabilizationImpaired autophagic fluxSystemic toxicityOff-target acidification of other organelles
06

Interacting drugs

Chloroquine

5 more in the full profile.

07

Biomarkers

Lysosomal-associated membrane protein 1 (LAMP1)Cathepsin DGlobotriaosylsphingosine (Lyso-Gb3)Glucosylsphingosine (Lyso-Gb1)

Beyond the preview

Go deeper on Lysosomal lumen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysosomal lumen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call